The G-2 Laboratory Index continues to show strength, with the 14 publicly traded laboratory stocks up 8 percent over the past five weeks for the week ended May 16, 2008. For the entire year, however, the Lab Index is down 6 percent, while the Nasdaq and S&P 500 continue to feel the impact of the sluggish economy. The Nasdaq is down 5.44 percent and the S&P 500 is down 3.59 percent so far in 2008.

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

June 2008 - Table of Contents

LIR June 2008 (full PDF issue)

Prices Dropping on Some DTC Genetic Tests as SACGHS Urges Tighter Regs

G-2 Predicts Global Mol Dx Industry to Reach $5.5 Billion in 2008, $8 Billion by 2010

Quest, LabCorp Revenue/Requisition Metrics Strengthen in Q1

LabCorp’s Partners With Siemens, Acquires Louisiana Lab

Cost and Profit Analysis Is Key to Capturing Revenue Potential of Mol Dx Lab

Q1 08 Lab Benchmark Data Reveal Psychemedics Still a Leader, Enzo Posts Gains

JVHL Teams With Clarient to Expand Cancer AP Menu

Orchid Cellmark Wins $30 Million Forensic Testing Contract in U.K.

Lab Stocks Continue to Post Gains in May, up 8% Over 5 Weeks

Economic Development Incentives Fuel Genzyme Genetics’s Staff Expansion in Santa Fe